Mr. Chair, I think what I'm trying to indicate is that the production of methamphetamine is a very important problem for the department and Canadians. We put a tool in place. It mitigates that risk. The other benefit is that it allows the natural health product to still be sold, so it's a very well-tailored instrument to use.
That's really the departmental thinking, and the supplemental rules set-up actually allows for that balance between availability, still, and making sure that abuse doesn't occur. That's really what I think the intention is of the instrument.